PMID: 6405303Jun 1, 1983Paper

Comparison of thyrotropin-releasing hormone (TRH), naloxone, and dexamethasone treatments in experimental spinal injury

Neurology
A I FadenJ W Holaday

Abstract

We have shown that early treatment with either naloxone or thyrotropin-releasing hormone (TRH) significantly improves neurologic outcome after experimental spinal injury. Because these previous studies used different injury variables, no conclusion could be made about the relative effectiveness of the two drugs. In the present study naloxone and TRH treatment (each 2 mg per kilogram bolus, 2 mg per kilogram per hour for 4 hours) were directly compared; other cats received either dexamethasone (0.5 mg per kilogram bolus, 0.5 mg per kilogram per hour) or saline. The spinal cord was traumatized at C-7, using the Allen method; treatment was begun 1 hour after injury. Neurologic function was graded between 0 and 10, using an ordinal rating scale. Both TRH- and naloxone-treated animals had significantly better functional scores than saline controls at 6 weeks postinjury. Moreover, TRH-treated cats also showed significantly better neurologic recovery than either naloxone- or dexamethasone-treated animals. These findings confirm the therapeutic benefit of TRH and naloxone in experimental spinal injury and indicate that TRH treatment is most effective. In contrast, corticosteroid treatment was of no benefit in the present model.

Citations

Jan 1, 1993·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·H AkdemirA Paşaoğlu
May 1, 1984·Canadian Anaesthetists' Society Journal·B Milne, K Jhamandas
Jan 1, 1990·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·S CeylanS Ceylan
Jul 8, 1985·Brain Research·L J YoungsM E Selzer
Sep 1, 1984·Peptides·G A OlsonA J Kastin
Jul 1, 1994·Neurobiology of Aging·G BenziR F Villa
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·P T Loosen
Jul 1, 1986·Brain Research Bulletin·D H Harkness, M S Brownfield
Aug 1, 1994·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·O PastorisR F Villa
Jul 22, 1999·Diabetes Research and Clinical Practice·H GulA Isimer
Aug 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·W Young
Apr 14, 2000·Neurosurgery·N Theodore, V K Sonntag
Apr 1, 1984·Journal of Neurosurgery·A I FadenM T Smith
Sep 1, 1985·Journal of Neurosurgery·E S FlammB Fischer
Jul 1, 1988·Journal of Neurosurgery·W G ObanaM C Nishimura
Mar 1, 1991·Journal of Neurosurgery·D W MarionH Yonas
May 18, 2000·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·A GörgülüS Cobanoğlu
Jan 1, 1989·Annals of the New York Academy of Sciences·T L MunsatS Reichlin
Jan 1, 1984·The American Journal of Emergency Medicine·J W Holaday
Oct 1, 1988·Experimental Neurology·A HenschenB Hoffer
Mar 1, 1986·The Journal of Surgical Research·T K McIntoshR H Egdahl
Jan 1, 1988·Annals of the New York Academy of Sciences·T L MunsatI M Jackson
May 1, 1990·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·S TagliaviniA Bertolini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.